INTELLIGENT BIO SOLUTIONS INC. Operating Income
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Operating Income of -$12.61 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for the quarter ending 2026-06-30 was -$3.97M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for the quarter ending 2026-03-31 was -$2.95M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for the quarter ending 2025-12-31 was -$2.64M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for the quarter ending 2025-09-30 was -$3.00M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for fiscal 2026 was -$12.61M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for fiscal 2025 was -$10.68M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for fiscal 2024 was -$10.28M.
- INTELLIGENT BIO SOLUTIONS INC. operating income (loss) for fiscal 2023 was -$12.60M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$6.92M derived: sum of 2 quarters · filed 2026-08-19 | -$9.55M derived: sum of 3 quarters · filed 2026-08-19 | -$12.61M 10-K · filed 2026-08-19 | |||
| 2026-03-31 | -$2.95M 10-Q · filed 2026-05-13 | -$5.58M derived: sum of 2 quarters · filed 2026-05-13 | -$8.64M 10-Q · filed 2026-05-13 | -$11.69M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | -$2.64M 10-Q · filed 2026-02-12 | -$5.64M 10-Q · filed 2026-02-12 | -$8.74M derived: sum of 3 quarters · filed 2026-08-19 | -$11.30M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-09-30 | -$3.00M 10-Q · filed 2025-11-12 | -$6.11M derived: sum of 2 quarters · filed 2026-08-19 | -$8.67M derived: sum of 3 quarters · filed 2026-08-19 | -$10.93M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | -$3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$5.67M derived: sum of 2 quarters · filed 2026-08-19 | -$7.93M derived: sum of 3 quarters · filed 2026-08-19 | -$10.68M 10-K · filed 2026-08-19 | -$10.64M 10-K · filed 2025-08-15 | ||
| 2025-03-31 | -$2.56M 10-Q · filed 2026-05-13 | -$2.55M 10-Q · filed 2025-05-13 | -$4.82M derived: sum of 2 quarters · filed 2026-05-13 | -$7.57M 10-Q · filed 2026-05-13 | -$7.54M 10-Q · filed 2025-05-13 | -$10.36M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$2.26M 10-Q · filed 2026-02-12 | -$4.99M 10-Q · filed 2026-02-12 | -$7.80M derived: sum of 3 quarters · filed 2026-02-12 | -$10.76M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | -$2.73M 10-Q · filed 2025-11-12 | -$5.54M derived: sum of 2 quarters · filed 2025-11-12 | -$8.49M derived: sum of 3 quarters · filed 2025-11-12 | -$10.48M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$5.77M derived: sum of 2 quarters · filed 2025-08-15 | -$7.76M derived: sum of 3 quarters · filed 2025-08-15 | -$10.28M 10-K · filed 2025-08-15 | |||
| 2024-03-31 | -$2.95M 10-Q · filed 2025-05-13 | -$4.95M derived: sum of 2 quarters · filed 2025-05-13 | -$7.47M 10-Q · filed 2025-05-13 | -$10.17M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$1.99M 10-Q · filed 2025-02-13 | -$4.52M 10-Q · filed 2025-02-13 | -$7.22M derived: sum of 3 quarters · filed 2025-02-13 | -$13.76M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | -$2.53M 10-Q · filed 2024-11-07 | -$5.23M derived: sum of 2 quarters · filed 2024-11-07 | -$11.77M derived: sum of 3 quarters · filed 2024-11-07 | -$13.90M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$9.25M derived: sum of 2 quarters · filed 2024-09-18 | -$11.38M derived: sum of 3 quarters · filed 2024-09-18 | -$12.60M 10-K · filed 2024-09-18 | |||
| 2023-03-31 | -$6.54M 10-Q · filed 2024-05-08 | -$8.67M derived: sum of 2 quarters · filed 2024-05-08 | -$9.89M 10-Q · filed 2024-05-08 | -$11.98M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | -$2.13M 10-Q · filed 2024-02-09 | -$3.35M 10-Q · filed 2024-02-09 | -$5.44M derived: sum of 3 quarters · filed 2024-02-09 | -$6.78M derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-09-30 | -$1.22M 10-Q · filed 2023-11-08 | -$3.31M derived: sum of 2 quarters · filed 2023-11-08 | -$4.65M derived: sum of 3 quarters · filed 2023-11-08 | -$8.12M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$3.43M derived: sum of 2 quarters · filed 2023-08-23 | -$6.90M derived: sum of 3 quarters · filed 2023-08-23 | -$8.34M 10-K · filed 2023-08-23 | |||
| 2022-03-31 | -$1.34M 10-Q · filed 2023-05-11 | -$4.81M derived: sum of 2 quarters · filed 2023-05-11 | -$6.25M 10-Q · filed 2023-05-11 | -$7.10M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$3.47M 10-Q · filed 2023-02-14 | -$4.91M 10-Q · filed 2023-02-14 | -$5.76M derived: sum of 3 quarters · filed 2023-02-14 | -$8.90M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-09-30 | -$1.44M 10-Q · filed 2022-11-14 | -$2.29M derived: sum of 2 quarters · filed 2022-11-14 | -$5.43M derived: sum of 3 quarters · filed 2022-11-14 | -$6.35M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$852.65K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | -$3.99M derived: sum of 2 quarters · filed 2022-09-22 | -$4.91M derived: sum of 3 quarters · filed 2022-09-22 | -$5.57M 10-K · filed 2022-09-22 | |||
| 2021-03-31 | -$3.14M 10-Q · filed 2022-05-16 | -$4.06M derived: sum of 2 quarters · filed 2022-05-16 | -$4.72M 10-Q · filed 2022-05-16 | -$5.23M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | -$917.33K 10-Q · filed 2022-02-11 | -$1.58M 10-Q · filed 2022-02-11 | -$2.09M derived: sum of 3 quarters · filed 2022-02-11 | -$2.12M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-09-30 | -$663.00K 10-Q · filed 2021-11-12 | -$1.17M derived: sum of 2 quarters · filed 2021-11-12 | -$1.20M derived: sum of 3 quarters · filed 2021-11-12 | -$2.90M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$508.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | -$537.72K derived: sum of 2 quarters · filed 2021-09-16 | -$2.24M derived: sum of 3 quarters · filed 2021-09-16 | -$2.86M 10-K · filed 2021-09-16 | |||
| 2020-03-31 | -$28.82K 10-Q · filed 2021-05-13 | -$1.73M derived: sum of 2 quarters · filed 2021-05-13 | -$2.35M 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$1.70M 10-Q · filed 2021-02-12 | -$2.32M 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |